Subclinical Plasmodium falciparum infection and HIV-1 viral load.
Brouwer
Kimberly C
KC
Mirel
Lisa B
LB
Yang
Chunfu
C
Lal
Renu B
RB
Kolczak
Margarette S
MS
Van Eijk
Anne M
AM
Ayisi
John
J
Otieno
Juliana A
JA
Nahlen
Bernard L
BL
Steketee
Richard
R
Shi
Ya Ping
YP
Lal
Altaf A
AA
D000328:Adult; D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use; D004338:Drug Combinations; D015658:HIV Infections / Q000097:blood / Q000150:complications* / Q000821:virology*; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D007223:Infant; D007630:Kenya; D016778:Malaria, Falciparum / Q000150:complications* / Q000175:diagnosis* / Q000469:parasitology; D010963:Plasmodium falciparum / Q000502:physiology; D011739:Pyrimethamine / Q000627:therapeutic use; D013413:Sulfadoxine / Q000627:therapeutic use; D019562:Viral Load
D000962:Antimalarials; D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine